UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Pediatrics (Evanston), 2001-09, Vol.108 (3), p.E48-e48

2001

Volltextzugriff (PDF)

Continuous end-tidal CO2 in pediatric bronchoscopy

Pediatric pulmonology, 1993-09, Vol.16 (3), p.153-157

1993

Volltextzugriff (PDF)

Continuous end‐tidal CO 2 in pediatric bronchoscopy

Pediatric pulmonology, 1993-09, Vol.16 (3), p.153-157

1993

Volltextzugriff (PDF)

Familial pulmonary nodular lymphoid hyperplasia

The Journal of pediatrics, 1992-07, Vol.121 (1), p.89-92

1992

Volltextzugriff (PDF)

Endobronchial Tuberculosis Presenting as Respiratory Failure in an Infant

Clinical pediatrics, 1993-12, Vol.32 (12), p.747-749

1993

Volltextzugriff (PDF)

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005-1014

2014

Volltextzugriff (PDF)

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2016-05, Vol.67 (17), p.1994-2004

2016

Volltextzugriff (PDF)

Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy

Gynecologic oncology, 2018-09, Vol.150 (3), p.438-445

2018

Volltextzugriff (PDF)

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study

Journal of the American College of Cardiology, 2016-05, Vol.67 (17), p.1994-2004

2016

Volltextzugriff (PDF)

Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases

Head & neck pathology (Totowa, N.J.), 2021-12, Vol.15 (4), p.1192-1201

2021

Volltextzugriff (PDF)

Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated Patients

JACC. Cardiovascular interventions, 2014-04, Vol.7 (4), p.426-434

2014

Volltextzugriff (PDF)

Measuring effusion rates of obsidian lava flows by means of satellite thermal data

Journal of volcanology and geothermal research, 2017-11, Vol.347, p.82-90

2017

Volltextzugriff (PDF)

IMPACT OF CHRONIC KIDNEY DISEASE ON THE PHARMACODYNAMIC AND PHARMACOKINETIC PROFILES OF CLOPIDOGREL IN THE SETTING OF TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.1161-1161

2024

Volltextzugriff (PDF)

IMPACT OF RACE ON PLATELET REACTIVITY PROFILES IN PATIENTS ON CLOPIDOGREL TREATMENT

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.849-849

2024

Volltextzugriff (PDF)

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study

Thrombosis and haemostasis, 2024-03, Vol.124 (3), p.263-273

2024

Volltextzugriff (PDF)

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

European heart journal, 2016-09, Vol.37 (35), p.2722-2730

2016

Volltextzugriff (PDF)

TAILORING P2Y12 INHIBITING THERAPY IN PATIENTS REQUIRING ORAL ANTICOAGULATION AFTER UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: THE SWITCHING ANTI-PLATELET AND ANTI-COAGULANT THERAPY (SWAP-AC)-2 STUDY

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.847-847

2024

Volltextzugriff (PDF)

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study

JACC. Cardiovascular interventions, 2023-01, Vol.16 (1), p.36-46

2023

Volltextzugriff (PDF)

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation

JACC. Cardiovascular interventions, 2015-09, Vol.8 (11), p.1457

2015

Volltextzugriff (PDF)

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study

JACC. Cardiovascular interventions, 2023-10, Vol.16 (20), p.2528-2539

2023

Volltextzugriff (PDF)

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023-03, Vol.18 (15), p.1254

2023

Volltextzugriff (PDF)

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2024-06, Vol.17 (11), p.1356-1370

2024

Volltextzugriff (PDF)

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor

JACC. Cardiovascular interventions, 2023-01, Vol.16 (1), p.36-46

2023

Volltextzugriff (PDF)

Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru

Revista peruana de medicina experimental y salud pública, 2023-04, Vol.40 (2), p.200-206

2023

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Continuous end-tidal CO2 in pediatric bronchoscopy

Continuous end‐tidal CO 2 in pediatric bronchoscopy

Familial pulmonary nodular lymphoid hyperplasia

Endobronchial Tuberculosis Presenting as Respiratory Failure in an Infant

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study

Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases

Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated Patients

Measuring effusion rates of obsidian lava flows by means of satellite thermal data

IMPACT OF CHRONIC KIDNEY DISEASE ON THE PHARMACODYNAMIC AND PHARMACOKINETIC PROFILES OF CLOPIDOGREL IN THE SETTING OF TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE

IMPACT OF RACE ON PLATELET REACTIVITY PROFILES IN PATIENTS ON CLOPIDOGREL TREATMENT

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

TAILORING P2Y12 INHIBITING THERAPY IN PATIENTS REQUIRING ORAL ANTICOAGULATION AFTER UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: THE SWITCHING ANTI-PLATELET AND ANTI-COAGULANT THERAPY (SWAP-AC)-2 STUDY

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor

Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru

Suchergebnisse filtern